Body Mass Index, Hormone Replacement Therapy, and Endometrial Cancer Risk: A Meta-Analysis

Cancer Epidemiology Biomarkers and Prevention - United States
doi 10.1158/1055-9965.epi-10-0832
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Body Mass and Endometrial Cancer Risk by Hormone Replacement Therapy and Cancer Subtype

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2008English

Hormone Replacement Therapy and the Risk of Endometrial Cancer: A Summary

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
1989English

Menopausal Hormone Replacement Therapy and the Risk of Ovarian Cancer: A Meta-Analysis

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2019English

Modelling Body Mass Index and Endometrial Cancer Risk in a Pooled-Analysis of Three Case-Control Studies

BJOG: An International Journal of Obstetrics and Gynaecology
GynecologyObstetrics
2015English

Body Mass Index and Colon Cancer Screening: A Systematic Review and Meta-Analysis

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2012English

Association Between Hormone Replacement Therapy and Subsequent Stroke: A Meta-Analysis

British Medical Journal
Medicine
2005English

Hormone Replacement Therapy and Risk of Epithelial Ovarian Cancer

British Journal of Cancer
Cancer ResearchOncology
1999English

Body Mass Index and Risk of Gastric Cancer in Asian Adults: A Meta-Epidemiological Meta-Analysis of Population-Based Cohort Studies

Cancer Research and Treatment
Cancer ResearchOncology
2020English

Quantitative Association Between Body Mass Index and the Risk of Cancer: A Global Meta-Analysis of Prospective Cohort Studies

International Journal of Cancer
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy